Crescent Capital BDC (NASDAQ:CCAP) Announces Quarterly Earnings Results

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) released its earnings results on Wednesday. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01), Zacks reports. Crescent Capital BDC had a return on equity of 12.20% and a net margin of 47.06%.

Crescent Capital BDC Price Performance

Shares of CCAP stock remained flat at $20.00 on Wednesday. The stock had a trading volume of 145,729 shares, compared to its average volume of 86,210. The stock’s fifty day moving average price is $19.47 and its 200 day moving average price is $18.85. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. Crescent Capital BDC has a 1-year low of $16.18 and a 1-year high of $20.19. The stock has a market cap of $741.20 million, a PE ratio of 7.84 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.40%. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date was Tuesday, December 31st. Crescent Capital BDC’s dividend payout ratio is presently 65.88%.

Analyst Upgrades and Downgrades

Several research firms have commented on CCAP. Wells Fargo & Company lifted their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 29th. Keefe, Bruyette & Woods upped their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $19.33.

Read Our Latest Report on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Read More

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.